This animal study found that GHK-Cu helps repair damaged fascia (connective tissue) by delivering copper to specific parts of cells where it’s needed. The copper activates enzymes that build collagen and promotes blood vessel formation, leading to better tissue healing. In rabbits with fascia injuries, this approach significantly improved tissue repair and regeneration.
This research review examines how activating estrogen-related receptors (ERRα/β/γ) can mimic the beneficial effects of physical exercise at the molecular level. The study focuses on SLU-PP-332, a compound that targets these receptors to potentially provide exercise-like metabolic benefits for patients who cannot engage in regular physical activity. This pharmacological approach could help address chronic diseases linked to sedentary lifestyles by activating the same cellular pathways that exercise normally triggers. The research suggests promise for treating metabolic dysfunction in physically inactive patients.
This study found that NMN supplementation can reduce inflammation by blocking the release of inflammatory molecules from aging cells. When cells become senescent (aged and damaged), they normally secrete harmful inflammatory substances that contribute to chronic diseases and aging. NMN appears to prevent this inflammatory secretion by boosting cellular energy levels and activating protective proteins. This suggests NMN could help combat age-related inflammation and its associated health problems.
This review article examined multiple classes of antiarrhythmic agents—including conventional Class I-IV antiarrhythmics, late sodium current inhibitors, potassium channel enhancers, ryanodine receptor stabilizers, gap junction modulators, atrial-selective agents, and the peptide BPC 157—and their proposed cytoprotective mechanisms in managing cardiac arrhythmias. The authors synthesized evidence suggesting these various drug classes may provide cardioprotection through different cellular pathways, though the review does not present new experimental data comparing efficacy. This is a **review article** synthesizing existing literature rather than original human clinical or experimental research.
Halting Self-Affirmed GRAS Without Notification Tops Kennedy’s 2026 Food Safety ‘Deliverables’ Citeline News & Insights
More parents are refusing vitamin K shots for newborns, doctors say. Here’s why that could be dangerous ABC News – Breaking News, Latest News and Videos
Researchers used Fourier Transform Infrared Spectroscopy to examine how the peptide BPC 157 affected aortic wall composition and structure in rats that underwent unilateral adrenalectomy (removal of one adrenal gland). The study identified specific changes in protein and collagen organization within the aortic tissue following BPC 157 treatment compared to control animals. **Evidence level: Animal model (rat study).**
Research Summary
Researchers developed inflammation-triggered self-immolative conjugates designed to deliver peptides orally by protecting them from gastrointestinal degradation and enhancing intestinal absorption in an animal model. The conjugates were engineered to release their peptide payload specifically in response to inflammatory markers present in the gastrointestinal tract, potentially enabling oral administration of peptides like KPV that are normally destroyed by stomach acid and digestive enzymes. This is an animal model study published in *Science Advances*.
This animal model study investigated safranal-standardized saffron extract in aged mice, examining its effects on metabolic function, cognitive performance, and anxiety-related behaviors through changes in hypothalamic-amygdalar peptide signaling. Researchers found that the saffron extract improved metabolic markers, cognitive outcomes, and anxiolytic (anxiety-reducing) measures in aged mice, with these improvements associated with modulation of peptides in brain regions involved in metabolism, learning, and emotional regulation. This is evidence-level animal model research that does not directly translate to human outcomes.
Peptide-based Cancer Therapeutics Market Size to Hit USD 24.85 Billion by 2035 Precedence Research
‘I don’t know how he’s alive’: RFK Jr. comments on Trump’s diet in new interview kare11.com
This animal model study in rats investigated whether the peptide BPC 157 could resolve tracheocutaneous fistulas (abnormal passages between the trachea and skin) through mechanisms involving the nitric oxide (NO) system. Researchers found that BPC 157 treatment promoted fistula healing and closure, with evidence suggesting involvement of three NO-related pathways. This is an animal model study and does not represent human clinical evidence.
